Abstract
Neuregulin1 (NRG1), a candidate susceptibility gene for schizophrenia, plays a critical role in neuronal migration and central nervous system development. However, its relation to schizophrenia pathogenesis is unknown. Here we show that B lymphoblasts migrate to NRG1 through the ErbB-signaling system as observed in neuronal cells. We assessed NRG1-induced cell migration in B lymphoblasts from patients with schizophrenia and found that NRG1-induced migration is significantly decreased compared with control individuals in two independent cohorts. This impaired migration is related at least in part to reduced AKT phosphorylation in the patients. Moreover, the magnitude of NRG1-induced migration is associated with polymorphisms of the NRG1 and catechol-o-methyltransferase genes and with an epistatic interaction of these genes. This study demonstrates that the migratory response of schizophrenia-derived cells to NRG1 is impaired and is associated with genetic variations in more than one schizophrenia susceptibility gene, providing a novel insight into potential neurodevelopmental mechanisms of schizophrenia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 1995; 60: 252–260.
Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F et al. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 1996; 153: 1534–1540.
Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD et al. NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet 1998; 81: 282–289.
Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998; 20: 70–73.
Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J et al. A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet 1998; 81: 364–376.
Brzustowicz LM, Honer WG, Chow EW, Little D, Hogan J, Hodgkinson K et al. Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet 1999; 65: 1096–1103.
Badner JA, Gershon ES . Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 405–411.
Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003; 73: 34–48.
Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877–892.
Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 83–87.
Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, Zammit S et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003; 8: 485–487.
Law AJ, Weickert CS, Hyde TM, Kleinman JE, Harrison PJ . Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 2004; 127: 125–136.
Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR . Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 2004; 9: 299–307.
Aston C, Jiang L, Sokolov BP . Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 2004; 77: 858–866.
Rimer M, Barrett DW, Maldonado MA, Vock VM, Gonzalez-Lima F . Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. NeuroReport 2005; 16: 271–275.
Gerlai R, Pisacane P, Erickson S . Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res 2000; 109: 219–227.
Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000; 26: 443–455.
Kwon OB, Longart M, Vullhorst D, Hoffman DA, Buonanno A . Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci 2005; 25: 9378–9383.
Ozaki M, Sasner M, Yano R, Lu HS, Buonanno A . Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 1997; 390: 691–694.
Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z . Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 2005; 25: 4974–4984.
Rieff HI, Raetzman LT, Sapp DW, Yeh HH, Siegel RE, Corfas G . Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci 1999; 19: 10757–10766.
Okada M, Corfas G . Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse. Hippocampus 2004; 14: 337–344.
Liu Y, Ford B, Mann MA, Fischbach GD . Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci 2001; 21: 5660–5669.
Harrison PJ, Weinberger DR . Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40–68.
Corfas G, Roy K, Buxbaum JD . Neuregulin 1–ErbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 2004; 7: 575–580.
Anton ES, Marchionni MA, Lee KF, Rakic P . Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 1997; 124: 3501–3510.
Rio C, Rieff HI, Qi P, Khurana TS, Corfas G . Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron 1997; 19: 39–50.
Flames N, Long JE, Garratt AN, Fischer TM, Gassmann M, Birchmeier C et al. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 2004; 44: 251–261.
Lopez-Bendito G, Cautinat A, Sanchez JA, Bielle F, Flames N, Garratt AN et al. Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell 2006; 125: 127–142.
Calaora V, Rogister B, Bismuth K, Murray K, Brandt H, Leprince P et al. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J Neurosci 2001; 21: 4740–4751.
Sussman CR, Vartanian T, Miller RH . The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation. J Neurosci 2005; 25: 5757–5762.
Colognato H, Ramachandrappa S, Olsen IM, ffrench-Constant C . Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 2004; 167: 365–375.
Kim JY, Sun Q, Oglesbee M, Yoon SO . The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo. J Neurosci 2003; 23: 5561–5571.
Weinberger DR, Marenco S . Schizophrenia as a neurodevelopmental disorder. In: Hirsch S, Weinberger DR (eds). Schizophrenia. Blackwell Science: Oxford, UK, 2003, pp 326–348.
Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H et al. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2004; 410: 948–952.
Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998; 95: 9448–9453.
Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR . Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595–599.
Weinberger DR . Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660–669.
Egan MF, Goldberg TE, Gscheidle T, Weirich M, Bigelow LB, Weinberger DR . Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry 2000; 157: 1309–1316.
Pressman S, Rotter JI . Epstein–Barr virus transformation of cryopreserved lymphocytes: prolonged experience with technique. Am J Hum Genet 1991; 49: 467.
Kato S, Kobayashi T, Yamada K, Nishii K, Sawada H, Ishiguro H et al. Expression of erbB receptors mRNA in thyroid tissues. Biochim Biophys Acta 2004; 1673: 194–200.
Kriebel PW, Barr VA, Parent CA . Adenylyl cyclase localization regulates streaming during chemotaxis. Cell 2003; 112: 549–560.
Marmor MD, Skaria KB, Yarden Y . Signal transduction and oncogenesis by ErbB/HER receptors. Int J Radiat Oncol Biol Phys 2004; 58: 903–913.
Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc Natl Acad Sci USA 2005; 103: 6747–6752.
Matsui A, Ikeda T, Enomoto K, Nakashima H, Omae K, Watanabe M et al. Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase. Cancer Lett 2000; 150: 23–31.
Leone F, Perissinotto E, Cavalloni G, Fonsato V, Bruno S, Surrenti N et al. Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells. J Leukoc Biol 2003; 74: 593–601.
Roy-Burman P, Devi BG, Parker JW . Differential expression of c-erbB, c-myc and c-myb oncogene loci in human lymphomas and leukemias. Int J Cancer 1983; 32: 185–191.
Buhring HJ, Sures I, Jallal B, Weiss FU, Busch FW, Ludwig WD et al. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia. Blood 1995; 86: 1916–1923.
Mahtouk K, Hose D, Reme T, De Vos J, Jourdan M, Moreaux J et al. Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene 2005; 24: 3512–3524.
Graus-Porta D, Beerli RR, Daly JM, Hynes NE . ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 1997; 16: 1647–1655.
Buonanno A, Fischbach GD . Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol 2001; 11: 287–296.
Falls DL . Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003; 284: 14–30.
Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA . Convergent evidence for impaired AKT1–GSK3beta signaling in schizophrenia. Nat Genet 2004; 36: 131–137.
Li Q, Ahmed S, Loeb JA . Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells. Cancer Res 2004; 64: 7078–7085.
Bao J, Wolpowitz D, Role LW, Talmage DA . Back signaling by the Nrg-1 intracellular domain. J Cell Biol 2003; 161: 1133–1141.
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917–6922.
Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75: 807–821.
Harrison PJ . The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593–624.
Acknowledgements
This research was supported by the Intramural Research Program of the National Institute of Mental Health, NIH. We thank Drs SP Markey and DL Murphy, NIMH, for their generous support, Drs CA Combs at the National Heart, Lung, and Blood Institute and C Smith at the National Institute of Neurological Disorders and Stroke for assistance with confocal microscopy, and DJ Venzon of the National Cancer Institute for statistical consultation and advice. We also thank Drs JW Daly of the National Institute of Diabetes and Digestive and Kidney Diseases, L Neckers of the National Cancer Institute and B Lu of the National Institute of Child Health and Human Development or scientific advice and critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)
Rights and permissions
About this article
Cite this article
Sei, Y., Ren-Patterson, R., Li, Z. et al. Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms. Mol Psychiatry 12, 946–957 (2007). https://doi.org/10.1038/sj.mp.4001994
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001994
Keywords
This article is cited by
-
NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia
Molecular Psychiatry (2020)
-
Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia
Scientific Reports (2017)
-
DNA methylation in schizophrenia in different patient-derived cell types
npj Schizophrenia (2017)
-
Neuregulin 1-Induced AKT and ERK Phosphorylation in Patients with Fragile X Syndrome (FXS) and Intellectual Disability Associated with Obstetric Complications
Journal of Molecular Neuroscience (2014)
-
Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity
Translational Psychiatry (2012)